United-Guardian Income After Taxes 2012-2026 | UG
United-Guardian income after taxes from 2012 to 2026. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
|
United-Guardian Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2025 | $2 |
| 2024 | $3 |
| 2023 | $3 |
| 2022 | $3 |
| 2021 | $5 |
| 2020 | $3 |
| 2019 | $5 |
| 2018 | $4 |
| 2017 | $4 |
| 2016 | $3 |
| 2015 | $5 |
| 2014 | $4 |
| 2013 | $6 |
| 2012 | $5 |
| 2011 | $5 |
|
United-Guardian Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2026-03-31 | $1 |
| 2025-12-31 | $1 |
| 2025-09-30 | $0 |
| 2025-06-30 | $1 |
| 2025-03-31 | $1 |
| 2024-12-31 | $1 |
| 2024-09-30 | $1 |
| 2024-06-30 | $1 |
| 2024-03-31 | $1 |
| 2023-12-31 | $1 |
| 2023-09-30 | $1 |
| 2023-06-30 | $0 |
| 2023-03-31 | $1 |
| 2022-12-31 | $1 |
| 2022-09-30 | $0 |
| 2022-06-30 | $1 |
| 2022-03-31 | $1 |
| 2021-12-31 | $1 |
| 2021-09-30 | $1 |
| 2021-06-30 | $1 |
| 2021-03-31 | $1 |
| 2020-12-31 | $1 |
| 2020-09-30 | $1 |
| 2020-06-30 | $1 |
| 2020-03-31 | $1 |
| 2019-12-31 | $1 |
| 2019-09-30 | $1 |
| 2019-06-30 | $1 |
| 2019-03-31 | $1 |
| 2018-12-31 | $1 |
| 2018-09-30 | $1 |
| 2018-06-30 | $1 |
| 2018-03-31 | $1 |
| 2017-12-31 | $1 |
| 2017-09-30 | $1 |
| 2017-06-30 | $1 |
| 2017-03-31 | $1 |
| 2016-12-31 | $1 |
| 2016-09-30 | $1 |
| 2016-06-30 | $0 |
| 2016-03-31 | $1 |
| 2015-12-31 | $0 |
| 2015-09-30 | $1 |
| 2015-06-30 | $2 |
| 2015-03-31 | $1 |
| 2014-12-31 | $1 |
| 2014-09-30 | $0 |
| 2014-06-30 | $1 |
| 2014-03-31 | $1 |
| 2013-12-31 | $2 |
| 2013-09-30 | $1 |
| 2013-06-30 | $1 |
| 2013-03-31 | $2 |
| 2012-12-31 | $1 |
| 2012-09-30 | $1 |
| 2012-06-30 | $1 |
| 2012-03-31 | $1 |
| 2011-12-31 | $1 |
| 2011-09-30 | $1 |
| 2011-06-30 | $1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.032B | $0.011B |
| UNITED GUARDIAN conducts research, product development, manufacturing and marketing of pharmaceuticals, cosmetics, health care products, medical devices, and proprietary industrial products. They also distributes a line of over 3,000 fine organic chemicals, research chemicals, test solutions, indicators, dyes and reagents. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $152.983B | 16.86 |
| Stryker (SYK) | United States | $116.806B | 22.75 |
| Medtronic (MDT) | Ireland | $101.469B | 14.34 |
| EssilorLuxottica (ESLOY) | France | $89.470B | 0.00 |
| Boston Scientific (BSX) | United States | $65.890B | 14.30 |
| Medline (MDLN) | United States | $45.598B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.521B | 0.00 |
| Agilent Technologies (A) | United States | $35.725B | 21.77 |
| GE HealthCare Technologies (GEHC) | United States | $27.585B | 13.30 |
| ResMed (RMD) | United States | $27.336B | 17.50 |
| Koninklijke Philips (PHG) | Netherlands | $26.518B | 15.42 |
| Terumo (TRUMY) | Japan | $20.489B | 22.77 |
| Zimmer Biomet Holdings (ZBH) | United States | $16.849B | 10.27 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.494B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.510B | 0.00 |
| Baxter (BAX) | United States | $10.154B | 9.45 |
| Insulet (PODD) | United States | $9.626B | 25.83 |
| Demant (WILYY) | Denmark | $8.153B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.523B | 30.33 |
| Lantheus Holdings (LNTH) | United States | $6.914B | 21.33 |
| BillionToOne (BLLN) | United States | $4.633B | 0.00 |
| Envista Holdings (NVST) | United States | $4.151B | 19.33 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.062B | 0.00 |
| ICU Medical (ICUI) | United States | $3.403B | 21.44 |
| Haemonetics (HAE) | United States | $3.296B | 14.59 |
| Curaleaf Holdings (CURLD) | Canada | $2.248B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.154B | 10.35 |
| GN Store Nord (GNNDY) | Denmark | $2.053B | 97.19 |
| LeMaitre Vascular (LMAT) | United States | $2.025B | 34.35 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.951B | 0.00 |
| Neogen (NEOG) | United States | $1.942B | 42.48 |
| Capricor Therapeutics (CAPR) | United States | $1.699B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.522B | 16.27 |
| AtriCure (ATRC) | United States | $1.440B | 948.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.356B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.328B | 3.74 |
| AdaptHealth (AHCO) | United States | $1.313B | 33.31 |
| Phibro Animal Health (PAHC) | United States | $1.260B | 10.60 |
| BioLife Solutions (BLFS) | United States | $1.217B | 207.50 |
| Kestra Medical Technologies (KMTS) | United States | $1.210B | 0.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.912B | 0.00 |
| QuidelOrtho (QDEL) | United States | $0.844B | 9.23 |
| InMode (INMD) | Israel | $0.759B | 9.57 |
| Omeros (OMER) | United States | $0.748B | 4.74 |
| CeriBell (CBLL) | United States | $0.690B | 0.00 |
| Brainsway (BWAY) | Israel | $0.577B | 41.09 |
| Tilray Brands (TLRY) | Canada | $0.535B | 0.00 |
| Cerus (CERS) | United States | $0.521B | 0.00 |
| Valneva SE (VALN) | France | $0.508B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.472B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.438B | 10.95 |
| Evolus (EOLS) | United States | $0.434B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.417B | 29.38 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.392B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.387B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.387B | 0.00 |
| SNDL (SNDL) | Canada | $0.360B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.359B | 17.46 |
| MacroGenics (MGNX) | United States | $0.291B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.286B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.258B | 0.00 |
| Accendra Health (ACH) | United States | $0.245B | 4.71 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Village Farms (VFF) | Canada | $0.214B | 8.50 |
| Utah Medical Products (UTMD) | United States | $0.211B | 19.57 |
| High Tide (HITI) | Canada | $0.201B | 57.25 |
| Sanara MedTech (SMTI) | United States | $0.199B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.198B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.176B | 47.83 |
| Apyx Medical (APYX) | United States | $0.168B | 0.00 |
| Quanterix (QTRX) | United States | $0.164B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.164B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Organigram Global (OGI) | Canada | $0.135B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.102B | 13.71 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| ImmuCell (ICCC) | United States | $0.088B | 0.00 |
| Biote (BTMD) | United States | $0.085B | 5.11 |
| Hongchang (HCIL) | China | $0.081B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.077B | 27.30 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.060B | 0.00 |
| Veru (VERU) | United States | $0.048B | 0.00 |
| Nephros (NEPH) | United States | $0.035B | 46.57 |
| Rockwell Medical (RMTI) | United States | $0.026B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.026B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.021B | 0.00 |
| Modular Medical (MODD) | United States | $0.020B | 0.00 |
| Jin Medical (ZJYL) | China | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Akanda (AKAN) | Canada | $0.008B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| INLIF (INLF) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |